A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II
Clinical trial NCT05055258 · TERMINATED
Trial details
- NCT number
- NCT05055258
- Sponsor
- KalVista Pharmaceuticals, Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2022-10-27
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.